AN: Regeneron CEO on President Trump’s use of company’s experimental antibody cocktail ((americasnewsroom__)) ((lubuntu at wor2))

Regeneron CEO Dr. Leonard Schleifer tells âAmericaâs Newsroomâ the company is trying to get expanded emergency use authorization from the FDA so others can access the treatment